Inhibitory feedback control of NF-κB signalling in health and disease
JA Prescott, JP Mitchell, SJ Cook - Biochemical Journal, 2021 - portlandpress.com
Cells must adapt to changes in their environment to maintain cell, tissue and organismal
integrity in the face of mechanical, chemical or microbiological stress. Nuclear factor-κB (NF …
integrity in the face of mechanical, chemical or microbiological stress. Nuclear factor-κB (NF …
Aggressive lymphomas
G Lenz, LM Staudt - New England Journal of Medicine, 2010 - Mass Medical Soc
This review summarizes recent evidence concerning molecular changes in the commonest
type of lymphoma, diffuse large-B-cell lymphoma. Detailed studies have revealed three …
type of lymphoma, diffuse large-B-cell lymphoma. Detailed studies have revealed three …
Oncogenically active MYD88 mutations in human lymphoma
The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) remains
the least curable form of this malignancy despite recent advances in therapy. Constitutive …
the least curable form of this malignancy despite recent advances in therapy. Constitutive …
A20: linking a complex regulator of ubiquitylation to immunity and human disease
A Ma, BA Malynn - Nature Reviews Immunology, 2012 - nature.com
A20 (also known as TNFAIP3) is a potent anti-inflammatory signalling molecule that restricts
multiple intracellular signalling cascades. Recent studies in three general areas have …
multiple intracellular signalling cascades. Recent studies in three general areas have …
A20 in inflammation and autoimmunity
L Catrysse, L Vereecke, R Beyaert, G van Loo - Trends in immunology, 2014 - cell.com
Although known for many years as a nuclear factor (NF)-κB inhibitory and antiapoptotic
signaling protein, A20 has recently attracted much attention because of its ubiquitin …
signaling protein, A20 has recently attracted much attention because of its ubiquitin …
Deubiquitinases in cancer: new functions and therapeutic options
JM Fraile, V Quesada, D Rodríguez, JMP Freije… - Oncogene, 2012 - nature.com
Deubiquitinases (DUBs) have fundamental roles in the ubiquitin system through their ability
to specifically deconjugate ubiquitin from targeted proteins. The human genome encodes at …
to specifically deconjugate ubiquitin from targeted proteins. The human genome encodes at …
Advances in understanding the pathogenesis of primary Sjögren's syndrome
G Nocturne, X Mariette - Nature Reviews Rheumatology, 2013 - nature.com
Primary Sjögren's syndrome (pSS) is a prototypic autoimmune disorder, management of
which has long suffered from a lack of knowledge of the underlying pathophysiological …
which has long suffered from a lack of knowledge of the underlying pathophysiological …
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
E Zucca, F Bertoni - Blood, The Journal of the American Society …, 2016 - ashpublications.org
Extranodal marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue
(MALT) arise from lymphoid populations that are induced by chronic inflammation in …
(MALT) arise from lymphoid populations that are induced by chronic inflammation in …
[HTML][HTML] Deubiquitinase inhibition as a cancer therapeutic strategy
P D'Arcy, X Wang, S Linder - Pharmacology & therapeutics, 2015 - Elsevier
The ubiquitin proteasome system (UPS) is the main system for controlled protein
degradation and a key regulator of fundamental cellular processes. The dependency of …
degradation and a key regulator of fundamental cellular processes. The dependency of …
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
L Vereecke, R Beyaert, G van Loo - Trends in immunology, 2009 - cell.com
Nuclear factor (NF)-κB has an important role in immunity and inappropriate NF-κB activity
has been linked with many autoimmune and inflammatory diseases. Multiple mechanisms …
has been linked with many autoimmune and inflammatory diseases. Multiple mechanisms …